No abstract available
MeSH terms
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Dipeptidyl Peptidase 4 / metabolism
-
Glucagon / pharmacology
-
Glucagon / therapeutic use
-
Glucagon-Like Peptide 1
-
Humans
-
Hypoglycemic Agents / pharmacology*
-
Hypoglycemic Agents / therapeutic use*
-
Peptide Fragments / pharmacology
-
Peptide Fragments / therapeutic use
-
Protease Inhibitors / pharmacology
-
Protease Inhibitors / therapeutic use
-
Protein Precursors / pharmacology
-
Protein Precursors / therapeutic use
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1
-
Protein Tyrosine Phosphatases / antagonists & inhibitors
-
Receptors, Cytoplasmic and Nuclear / agonists
-
Transcription Factors / agonists
Substances
-
Hypoglycemic Agents
-
Peptide Fragments
-
Protease Inhibitors
-
Protein Precursors
-
Receptors, Cytoplasmic and Nuclear
-
Transcription Factors
-
Glucagon-Like Peptide 1
-
Glucagon
-
PTPN1 protein, human
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1
-
Protein Tyrosine Phosphatases
-
Dipeptidyl Peptidase 4